Arbutus Biopharma
ABUS
#6131
Rank
S$1.17 B
Marketcap
S$6.13
Share price
1.70%
Change (1 day)
37.57%
Change (1 year)

Market capitalization of Arbutus Biopharma (ABUS)

Market cap: S$1.17 Billion

As of January 2026 Arbutus Biopharma has a market cap of S$1.17 Billion. This makes Arbutus Biopharma the world's 6131th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arbutus Biopharma from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.17 B-0.04%
2025S$1.18 B42.75%
2024S$0.82 B49.33%
2023S$0.55 B13.29%
2022S$0.48 B-36.42%
2021S$0.76 B92.76%
2020S$0.39 B64.24%
2019S$0.24 B-18.85%
2018S$0.29 B-19.55%
2017S$0.37 B91.25%
2016S$0.19 B-43.39%
2015S$0.34 B-23.53%
2014S$0.44 B133.52%
2013S$0.19 B121.68%
2012S$86.77 M267.68%
2011S$23.59 M-62.3%
2010S$62.59 M-6.26%
2009S$66.77 M217.36%
2008S$21.04 M-58.11%
2007S$50.22 M

End of Day market cap according to different sources

On Jan 6th, 2026 the market cap of Arbutus Biopharma was reported to be:

S$1.17 Billion
by Nasdaq info icon info icon
S$1.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NRC Health
NRC
S$0.57 B-51.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$23.37 M-98.02% Bahamas